RE:RE:RE:RE:News?FGPstock - you are blaming Theralase for not living up to the speculative posts of ScienceFirst, who is just another Stockhouse poster like you and me.
We've all got opinions. Why do you expect Theralase to live up to ScienceFirst's?
Theralase wrote they would submit the BTD application in December 2022, subject to the Clinical Study Sites (“CSS”) availability to complete all required assessments.
Don't you think it's possible that one or more study sites have not yet contributed their latest data, making it impossible for Theralase to submit the application?
Theralase never wrote anything about revenues in 1Q23. If a Stockhouse poster - ScienceFirst - interpreted their statements about the beginning of the "commercialization phase" this way this is not the fault of Theralase.